Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-26T11:13:01.790Z Has data issue: false hasContentIssue false

Biobank/Genomic Research in Nigeria: Examining Relevant Privacy and Confidentiality Frameworks

Published online by Cambridge University Press:  01 January 2021

Extract

Health research raises profound concerns of an ethical and legal nature — concerns primarily centered on how to balance researchers’ quest for scientific discovery against societal interest in protecting individuals whose participation makes the discovery possible. Particularly in a country such as Nigeria, which, not too long ago, suffered major abuse of research subjects (Pfizer’s clinical trial of Trovafloxacin and resulting death of eleven children in 1996), deploying a robust ethicolegal regime capable of curbing excesses and protecting research participants whilst contemporaneously not frustrating scientific progress is not an easy task. This is even more critical in the context of novel scientific endeavors, such as biobanking and genomic research, particularly when a significant pool of potential donors are inadequately informed about the processes involved in their participation or the result.

Type
Symposium
Copyright
Copyright © American Society of Law, Medicine and Ethics 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

National Human Genome Research Institute (NHGRI), “International HapMap Project,” available at <http://www.genome.gov/10001688> (last visited November 6, 2015).+(last+visited+November+6,+2015).>Google Scholar
de Vries, J. Abayomi, A. Littler, K. et al. , “Addressing Ethical Issues in H3Africa Research – The Views of Research Ethics Committee Members,” The Hugo Journal 9, no. 1 (2015): 14, at 1 [hereinafter cited as de Vries et al.].Google Scholar
United Nations Development Reports (UNDP), Human Development Report 2014: Sustaining Human Progress: Reducing Vulnerabilities and Building Resilience (New York: UNDP, 2014): At 218 [hereinafter cited as UNDP].Google Scholar
Id., at 216–219.Google Scholar
Central Intelligence Agency (CIA), “World Factbook: Nigeria,” available at <https://www.cia.gov/library/publications/the-world-factbook/geos/ni.html> (last visited November 6, 2015).+(last+visited+November+6,+2015).>Google Scholar
Forbes, , “Nigeria: Profile,” December 2014, available at <http://www.forbes.com/places/nigeria/> (last visited November 6, 2015).+(last+visited+November+6,+2015).>Google Scholar
PwC Economics, “World in 2050, the BRICs and Beyond: Prospects, Challenges and Opportunities,” at 2, January 2013, available at <http://www.eldis.org/go/home&id=66757&type=Document#.VXhQy_lVhBd> (last visited November 6, 2015).+(last+visited+November+6,+2015).>Google Scholar
U.S. Energy Information and Administration (IEA), Country Analysis Brief: Nigeria, at 1, available at <http://www.eia.gov/countries/analysisbriefs/Nigeria/nigeria.pdf> (last visited November 6, 2015).+(last+visited+November+6,+2015).>Google Scholar
Federal Ministry of Health (FMoH), National Health Policy 2004, ¶ 4.6 [hereinafter cited as National Health Policy].Google Scholar
Id., at ¶ 3.3.Google Scholar
National Health Act, (SB. 215) 2014, § 1(1)(c) [hereinafter cited as National Health Act].Google Scholar
See National Health Policy, supra note 10, at ¶ 3.2; Id., §1(1)(e).Google Scholar
See National Health Policy, supra note 10, at ¶ 3.1.Google Scholar
For a definition of MMR, see WHO, ICD-10 International Statistical Classification of Diseases and Related Health Problems (Malta: WHO, 2010): At 98.Google Scholar
World Health Organization (WHO), World Health Statistics 2014 (Geneva: WHO, 2014): At 82.Google Scholar
Id., at 90.Google Scholar
Figure derived from deducting 900 (equals 75 percent of MMR in 1990, which was 1200).Google Scholar
See UNDP, supra note 3, at 180.Google Scholar
Id., at 190.Google Scholar
Institute of Human Virology, Nigeria, Bio-repository Unit, available at <http://ihvnigeria.org/ihvnweb/webnew/index.php/officesdepts/clinical-lab-dept/bio-repository-unit.html> (last visited November 6, 2015).+(last+visited+November+6,+2015).>Google Scholar
Yakubu, A. Adebamowo, C. A., “Implementing National System of Health Research Ethics Regulation: The Nigerian Experience,” BeOnline Journal, 1, no. 1 (2012): 415 [hereinafter cited as Yakubu and Adebamowo].Google Scholar
Federal Ministry of Health (FMoH), National Code of Health Research Ethics, at 1, August 13, 2007 [hereinafter cited as National Code of Health Research Ethics].Google Scholar
See National Health Act, supra note 14, at § 33.Google Scholar
Id., at § 33(6).Google Scholar
Id., at § 34(1).Google Scholar
Id., at § 34(2).Google Scholar
See National Code of Health Research Ethics, supra note 31, at v.Google Scholar
Council for International Organizations of Medical Sciences (CIOMS), International Ethical Guidelines for Biomedical Research Involving Human Subjects, 1993 [hereinafter cited as CIOMS].Google Scholar
World Medical Association (WMA), Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects, 64th WMA General Assembly, Fortaleza, Brazil, October 2013, available at <http://www.wma.net/en/30publications/10policies/b3/> (last visited November 6, 2015) [hereinafter cited as Declaration of Helsinki].+(last+visited+November+6,+2015)+[hereinafter+cited+as+Declaration+of+Helsinki].>Google Scholar
Code of Federal Regulations, Title 45, Part 46, Protection of Human Subjects, July 14, 2009.Google Scholar
Indian Council of Medical Research, Ethical Guidelines for Biomedical Research on Human Participants, 2006, available at <http://icmr.nic.in/ethical_guidelines.pdf> (last visited November 6, 2015).+(last+visited+November+6,+2015).>Google Scholar
Department of Health, Ethics in Health Research: Principles, Structures and Processes, available at <http://www.mrc.ac.za/ethics/DOHEthics.pdf> (last visited November 6, 2015).+(last+visited+November+6,+2015).>Google Scholar
See Yakubu, Adebamowo, , supra note 29.Google Scholar
See National Code of Health Research Ethics, supra note 31, at 10–11.Google Scholar
Id., at 3.Google Scholar
Id., at 15.Google Scholar
Id., at 14.Google Scholar
Id., at 17.Google Scholar
Id., at 20.Google Scholar
Id., at 20–21.Google Scholar
Id., at 24.Google Scholar
Id., at 37.Google Scholar
Id., at 38.Google Scholar
Id., at 39.Google Scholar
See CIOMS, supra note 38, at Guideline 3 (Commentary on Guideline 3).Google Scholar
See National Code of Health Research Ethics, supra note 31, at 40.Google Scholar
Id., at 28.Google Scholar
Id., at 29.Google Scholar
Id., at 31.Google Scholar
National Health Research Ethics Committee of Nigeria (NHREC), Policy Statement on Storage of Human Samples in Biobanks and Biorepositories in Nigeria (PS1.02013), at 1, November 1, 2013 [hereinafter cited as NHREC].Google Scholar
Id., at 2.Google Scholar
Id., at 1.Google Scholar
Id., at 2–3.Google Scholar
Id., at 3.Google Scholar
See de Vries, et al. , supra note 2, at 2.Google Scholar
See NHREC, supra note 67, at 3.Google Scholar
Id., at 3–4.Google Scholar
Id., at 4.Google Scholar
See National Health Act, supra note 14, at § 33(1).Google Scholar
See NHREC, supra note 67, at 2.Google Scholar
Id., at 1.Google Scholar
See National Health Act, supra note 14, at § 26.Google Scholar
See NHREC, supra note 67, at 3–4.Google Scholar
Matimba, A. Oluka, M. N. Ebeshi, B. U. et al. , “Establishment of a Biobank and Pharmacogenetics Database of African Populations,” European Journal of Human Genetics 16 (2008): 780785, at 781.Google Scholar
See National Health Act, supra note 14, at § 32(1)(b).Google Scholar
See NHREC, supra note 67, at 3.Google Scholar
See National Code of Health Research Ethics, supra note 31, at 37.Google Scholar
See Declaration of Helsinki, supra note 39, at ¶ 32.Google Scholar
See National Code of Health Research Ethics, supra note 31, at 37–38.Google Scholar
See CIOMS, supra note 38, at Guideline 2 (Commentary on Guideline 2) and Guideline 3.Google Scholar
See National Code of Health Research Ethics, supra note 31, at 39.Google Scholar
See CIOMS, supra note 38, at Guideline 3.Google Scholar
Staunton, C. Moodley, K., “Challenges in Biobank Governance in Sub-Sahara Africa,” BMC Medical Ethics 14, no. 35 (2013), available at <http://www.biomedcentral.com/14726939/14/35> (last visited November 6, 2015).CrossRefGoogle Scholar
See NHREC, supra note 67, at 3.Google Scholar
Igbe, M. A. Adebamowo, C. A., “Qualitative Study of Knowledge and Attitudes to Biobanking among Lay Persons in Nigeria,” BMC Medical Ethics 13, no. 27 (2012), available at <http://www.biomedcentral.com/1472–6939/13/27> (last visited November 6, 2015).CrossRefGoogle Scholar
H3Africa Working Group on Ethics and Regulatory Issues for the Human Heredity and Health (H3Africa) Consortium, H3Africa Guidelines for Informed Consent, at 2, August 2013, available at <http://h3africa.org/images/FinalPoliciesDocuments/H3A%20WG%20Guidelines%20Informed%20Consent_FINAL_01082013.pdf> (last visited November 6, 2015) [hereinafter cited as H3Africa Working Group].+(last+visited+November+6,+2015)+[hereinafter+cited+as+H3Africa+Working+Group].>Google Scholar
See NHREC, supra note 67, at 3.Google Scholar
See National Code of Health Research Ethics, supra note 31, at 24.Google Scholar
See H3Africa Working Group, supra note 98, at 2.Google Scholar
Id., at 15.Google Scholar
Id., at 9–10.Google Scholar
See National Health Act, supra note 14, § 32(1) (b).Google Scholar
See National Code of Health Research Ethics, supra note 31, at 39.Google Scholar
H3Africa Consortium, “Enabling the Genomic Revolution in Africa,” Science 344, no. 6190 (2014), available at <http://www.sciencemag.org/content/344/6190/1346> (last visited November 6, 2015).+(last+visited+November+6,+2015).>Google Scholar
World Health Organization (WHO), The World Health Report 2000 – Health System: Improving Performance (Geneva: WHO, 2014): At 152–154.Google Scholar